Supply Chain (SCM/SCE)

Supply Chain Management (SCM) & Supply Chain Execution (SCE) Software, Products & Solutions including Supply Chain Optimisation, hardware transport, supply-chain distribution software, freight software as well as load planning, vehicle routing & scheduling software in manufacturing and supply chain applications.

Axonics Announces Listing on the UK National Health Service Supply Chain for Its Sacral Neuromodulation System

29-Nov-2018
Axonics Announces Listing on the UK National Health Service Supply Chain for Its Sacral Neuromodulation System
Axonics Modulation Technologies, Inc., a medical technology company focused on the design, development and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions for the treatment of urinary and bowel dysfunction, announced today that the Axonics r-SNM™ System has been listed on the U.K.’s National Health Service Supply Chain (“NHS SC”) online catalogue, thereby allowing wide commercial distribution to NHS hospitals in England.

Listing on the NHS SC online catalogue is a key step toward broader availability of new medical technologies and orders for the Company’s product are already being received and shipped. The Axonics r-SNM System is the first rechargeable SNM system approved for sale in the U.K. for patients suffering from overactive bladder, fecal incontinence and urinary retention.

Raymond W. Cohen, CEO of Axonics, commented, “Following the effort initiated by the NHS to centralize medical device purchasing for its hospitals, listing on the NHS SC online catalogue is critical to conduct business in England. We are now well positioned for physicians to select and implant the Axonics solution for the benefit of a broader range of patients. These early orders are important as we establish our brand and create referral sites in England. Given the cost-saving aspect of our long-lived r-SNM implant and innovative product features, we are optimistic about our ability to further penetrate the market in the U.K. in 2019.”